Lawrence PLC
2 May 2002
Lawrence plc - New Distribution Agreement -
Further Animal Health Drug Registrations
-------------------------------------------------------------------------------
The Board is pleased to announce that our ECO Animal Health subsidiary (ECO) has
gained a further registration for a Cattle Pour On in the UK. The Janssen
Animal Health division of Johnson & Johnson will now sell this cattle
antiparasitic under the brand name QUALIMINTIC. This follows a very successful
relationship between the two companies in Europe. ECO intends to continue with
this multi branding approach in the UK and expects UK sales in the current
financial year attributable to this product to be in excess of £1 million.
We have also been awarded, through our office in Shanghai, a registration for
ECOMECTIN Injection in China where it will be used primarily as an antiparasitic
in pigs. We are in the process of appointing local distributors and expect
sales to start later this year. China is a very large market as over half a
billion pigs are consumed there annually: The Directors therefore consider that
the sales potential for ECOMECTIN is very substantial.
We are expecting further important drug registrations over the coming months and
will keep shareholders advised of progress.
We have launched a new corporate web site www.lawrenceplc.com to include our
recent press releases, together with general information about the company and
its subsidiaries. Each subsidiary also has a web site, which gives further
information about that business and its products.
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro financial
020 8949 0428
Robert Corden
Charles Stanley & Co
020 7953 2219
02 May 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.